Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Global Medical REIT (GMRE-PA) over the last 14 years, with Q3 2025 value amounting to $614000.0.

  • Global Medical REIT's Net Cash Flow rose 221724.14% to $614000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 105875.71%. This contributed to the annual value of $2.2 million for FY2024, which is 12868.97% up from last year.
  • Per Global Medical REIT's latest filing, its Net Cash Flow stood at $614000.0 for Q3 2025, which was up 221724.14% from $1.6 million recorded in Q2 2025.
  • Global Medical REIT's 5-year Net Cash Flow high stood at $6.0 million for Q2 2022, and its period low was -$4.6 million during Q1 2022.
  • Over the past 5 years, Global Medical REIT's median Net Cash Flow value was $12000.0 (recorded in 2024), while the average stood at -$48052.6.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 80618.24% in 2022, then soared by 1355000.0% in 2025.
  • Quarter analysis of 5 years shows Global Medical REIT's Net Cash Flow stood at $890000.0 in 2021, then dropped by 3.37% to $860000.0 in 2022, then plummeted by 203.26% to -$888000.0 in 2023, then soared by 229.84% to $1.2 million in 2024, then plummeted by 46.75% to $614000.0 in 2025.
  • Its Net Cash Flow was $614000.0 in Q3 2025, compared to $1.6 million in Q2 2025 and -$1.4 million in Q1 2025.